The clot-dissolving medication, alteplase, improved stroke patients' recovery by more than 50% when given up to 24 hours after the beginning of an ischemic stroke, according to preliminary ...

CEO Haruo Naito highlighted a 9% year-on-year revenue increase to 601.2 billion yen, with a focus on the pharmaceutical business driving growth. Key contributors included LEQEMBI with a 28.1 billion ...

Monitoring respiratory motion during diagnostic imaging and radiation therapy is crucial for accurate diagnosis and treatment ...

For the second time, Massachusetts General Hospital has transplanted a genetically edited pig kidney into a human.